bioAffinity Technologies (BIAF) Competitors $0.24 0.00 (-1.02%) Closing price 04:00 PM EasternExtended Trading$0.24 +0.00 (+0.78%) As of 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BIAF vs. RSLS, LUNA, SGRP, VCIG, MCTR, OFAL, JOB, ESGL, CJMB, and GFAIShould you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include ReShape Lifesciences (RSLS), Luna Innovations (LUNA), SPAR Group (SGRP), VCI Global (VCIG), CTRL Group (MCTR), OFA Group (OFAL), GEE Group (JOB), ESGL (ESGL), Callan JMB (CJMB), and Guardforce AI (GFAI). bioAffinity Technologies vs. Its Competitors ReShape Lifesciences Luna Innovations SPAR Group VCI Global CTRL Group OFA Group GEE Group ESGL Callan JMB Guardforce AI bioAffinity Technologies (NASDAQ:BIAF) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings. Which has more risk and volatility, BIAF or RSLS? bioAffinity Technologies has a beta of 2.53, indicating that its stock price is 153% more volatile than the S&P 500. Comparatively, ReShape Lifesciences has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Is BIAF or RSLS more profitable? ReShape Lifesciences has a net margin of -69.71% compared to bioAffinity Technologies' net margin of -152.16%. ReShape Lifesciences' return on equity of -547.65% beat bioAffinity Technologies' return on equity.Company Net Margins Return on Equity Return on Assets bioAffinity Technologies-152.16% -845.68% -181.92% ReShape Lifesciences -69.71%-547.65%-79.89% Which has stronger earnings and valuation, BIAF or RSLS? ReShape Lifesciences has lower revenue, but higher earnings than bioAffinity Technologies. bioAffinity Technologies is trading at a lower price-to-earnings ratio than ReShape Lifesciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiobioAffinity Technologies$9.36M0.74-$9.04M-$0.70-0.35ReShape Lifesciences$8.01M1.06-$7.13M-$108.27-0.03 Do analysts prefer BIAF or RSLS? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00ReShape Lifesciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer BIAF or RSLS? In the previous week, bioAffinity Technologies had 1 more articles in the media than ReShape Lifesciences. MarketBeat recorded 2 mentions for bioAffinity Technologies and 1 mentions for ReShape Lifesciences. ReShape Lifesciences' average media sentiment score of 1.88 beat bioAffinity Technologies' score of 0.63 indicating that ReShape Lifesciences is being referred to more favorably in the news media. Company Overall Sentiment bioAffinity Technologies Positive ReShape Lifesciences Very Positive Do insiders and institutionals hold more shares of BIAF or RSLS? 1.6% of bioAffinity Technologies shares are owned by institutional investors. Comparatively, 22.1% of ReShape Lifesciences shares are owned by institutional investors. 16.9% of bioAffinity Technologies shares are owned by company insiders. Comparatively, 0.0% of ReShape Lifesciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryReShape Lifesciences beats bioAffinity Technologies on 8 of the 14 factors compared between the two stocks. Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIAF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIAF vs. The Competition Export to ExcelMetricbioAffinity TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.89M$3.08B$5.76B$9.75BDividend YieldN/A2.26%3.95%4.02%P/E Ratio-0.3520.9231.4426.39Price / Sales0.74355.43431.83159.31Price / CashN/A44.7137.7559.42Price / Book-3.038.0410.566.59Net Income-$9.04M-$53.98M$3.27B$265.83M7 Day Performance-4.53%-0.88%0.60%0.19%1 Month Performance-25.16%5.67%5.43%2.15%1 Year Performance-84.38%9.07%50.38%21.08% bioAffinity Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIAFbioAffinity Technologies0.5114 of 5 stars$0.24-1.0%N/A-84.5%$6.89M$9.36M-0.3510RSLSReShape Lifesciences0.1637 of 5 stars$3.16-1.4%N/A-99.6%$8.49M$8.01M-0.0350Gap DownHigh Trading VolumeLUNALuna Innovations0.1146 of 5 stars$0.80+3.9%N/A-61.9%$27.17M$116.61M0.00390Gap DownSGRPSPAR Group2.4866 of 5 stars$1.13+1.3%N/A-21.3%$26.41M$163.63M2.223,425VCIGVCI Global0.4278 of 5 stars$0.75-3.8%N/A-99.6%$24.31M$27.83M0.00102MCTRCTRL GroupN/A$1.55+5.4%N/AN/A$22.49MN/A0.0020Positive NewsHigh Trading VolumeOFALOFA GroupN/A$1.52-3.8%N/AN/A$22MN/A0.006Gap DownJOBGEE Group0.8498 of 5 stars$0.20+1.7%N/A-26.6%$21.89M$108.75M-0.91310ESGLESGL0.5372 of 5 stars$2.60-2.6%N/A+95.1%$21.41M$6.10M0.00N/APositive NewsCJMBCallan JMBN/A$5.14+8.0%N/AN/A$21.33M$6.56M0.0035High Trading VolumeGFAIGuardforce AI3.2568 of 5 stars$1.18+7.3%$4.50+281.4%-19.7%$19.59M$36.35M0.001,547News CoverageHigh Trading Volume Related Companies and Tools Related Companies ReShape Lifesciences Competitors Luna Innovations Competitors SPAR Group Competitors VCI Global Competitors CTRL Group Competitors OFA Group Competitors GEE Group Competitors ESGL Competitors Callan JMB Competitors Guardforce AI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIAF) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access